Skip to main content
The BMJ logoLink to The BMJ
. 1995 Nov 18;311(7016):1345–1346. doi: 10.1136/bmj.311.7016.1345

Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.

M Impallomeni 1, N P Galletly 1, S J Wort 1, J M Starr 1, T R Rogers 1
PMCID: PMC2551248  PMID: 7496287

Full text

PDF
1345

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Golledge C. L., McKenzie T., Riley T. V. Extended spectrum cephalosporins and Clostridium difficile. J Antimicrob Chemother. 1989 Jun;23(6):929–931. doi: 10.1093/jac/23.6.929. [DOI] [PubMed] [Google Scholar]
  2. Green S. T., Mackie R., McMillan H., Davie J. W. Clostridium difficile induced colitis occurring during cefotaxime therapy. Ulster Med J. 1985 Apr;54(1):80–82. [PMC free article] [PubMed] [Google Scholar]
  3. Pear S. M., Williamson T. H., Bettin K. M., Gerding D. N., Galgiani J. N. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med. 1994 Feb 15;120(4):272–277. doi: 10.7326/0003-4819-120-4-199402150-00003. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES